Glory Health Industry Limited (FRA:84R)
0.0075
+0.0005 (7.14%)
At close: Nov 25, 2025
Glory Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 2,042 | 2,705 | 2,506 | 3,905 | 9,898 | 5,769 | Upgrade | |
Revenue Growth (YoY) | 0.25% | 7.94% | -35.81% | -60.55% | 71.58% | -28.72% | Upgrade |
Cost of Revenue | 1,914 | 2,150 | 2,557 | 3,791 | 8,651 | 4,789 | Upgrade |
Gross Profit | 127.66 | 555.56 | -50.28 | 113.52 | 1,247 | 980.32 | Upgrade |
Selling, General & Admin | 204.57 | 277.35 | 406.71 | 460.57 | 667.52 | 741.22 | Upgrade |
Operating Expenses | 236.09 | 308.87 | 411.13 | 528.65 | 751.22 | 741.22 | Upgrade |
Operating Income | -108.43 | 246.7 | -461.41 | -415.14 | 496.02 | 239.1 | Upgrade |
Interest Expense | -1,004 | -1,004 | -502.67 | -451.59 | -744.91 | -487.32 | Upgrade |
Interest & Investment Income | 65.34 | 65.58 | 73.56 | 74.26 | 83.94 | 122.97 | Upgrade |
Earnings From Equity Investments | -64.74 | -69.93 | -72.56 | 42.03 | 166.39 | -5.1 | Upgrade |
Currency Exchange Gain (Loss) | 32.81 | -13.72 | -18.76 | -350.02 | 444.53 | 245.28 | Upgrade |
Other Non Operating Income (Expenses) | -107.27 | -86.58 | -24.29 | -0.66 | 24.86 | 27.04 | Upgrade |
EBT Excluding Unusual Items | -1,186 | -861.63 | -1,006 | -1,101 | 470.82 | 141.97 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.17 | Upgrade |
Gain (Loss) on Sale of Assets | -26.06 | -17.72 | 146.12 | 2.45 | 332.01 | 59.88 | Upgrade |
Asset Writedown | -228.98 | -498.94 | 263.5 | 20.06 | 115.7 | 315.04 | Upgrade |
Other Unusual Items | -58.03 | -58.03 | -58.95 | -11.75 | -41.66 | - | Upgrade |
Pretax Income | -1,499 | -1,436 | -655.46 | -1,090 | 876.87 | 516.72 | Upgrade |
Income Tax Expense | 21.6 | -20.81 | -61.96 | -95.05 | 532.35 | 383.08 | Upgrade |
Earnings From Continuing Operations | -1,521 | -1,416 | -593.5 | -995.29 | 344.52 | 133.65 | Upgrade |
Minority Interest in Earnings | 114.13 | 175.07 | 29.53 | 82.51 | -116.18 | -34.91 | Upgrade |
Net Income | -1,407 | -1,240 | -563.97 | -912.78 | 228.33 | 98.74 | Upgrade |
Net Income to Common | -1,407 | -1,240 | -563.97 | -912.78 | 228.33 | 98.74 | Upgrade |
Net Income Growth | - | - | - | - | 131.25% | -88.52% | Upgrade |
Shares Outstanding (Basic) | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | Upgrade |
Shares Outstanding (Diluted) | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 | Upgrade |
Shares Change (YoY) | - | - | - | - | - | -0.09% | Upgrade |
EPS (Basic) | -0.32 | -0.28 | -0.13 | -0.21 | 0.05 | 0.02 | Upgrade |
EPS (Diluted) | -0.32 | -0.28 | -0.13 | -0.21 | 0.05 | 0.02 | Upgrade |
EPS Growth | - | - | - | - | 131.42% | -88.52% | Upgrade |
Free Cash Flow | 1,053 | 678.26 | 452.11 | 413.47 | 4,066 | 4,666 | Upgrade |
Free Cash Flow Per Share | 0.24 | 0.15 | 0.10 | 0.09 | 0.92 | 1.05 | Upgrade |
Gross Margin | 6.25% | 20.54% | -2.01% | 2.91% | 12.60% | 16.99% | Upgrade |
Operating Margin | -5.31% | 9.12% | -18.41% | -10.63% | 5.01% | 4.15% | Upgrade |
Profit Margin | -68.90% | -45.85% | -22.50% | -23.38% | 2.31% | 1.71% | Upgrade |
Free Cash Flow Margin | 51.54% | 25.07% | 18.04% | 10.59% | 41.08% | 80.88% | Upgrade |
EBITDA | -50.73 | 320.62 | -384.83 | -325.93 | 581.55 | 319.79 | Upgrade |
EBITDA Margin | -2.48% | 11.85% | -15.35% | -8.35% | 5.88% | 5.54% | Upgrade |
D&A For EBITDA | 57.7 | 73.93 | 76.58 | 89.2 | 85.53 | 80.68 | Upgrade |
EBIT | -108.43 | 246.7 | -461.41 | -415.14 | 496.02 | 239.1 | Upgrade |
EBIT Margin | -5.31% | 9.12% | -18.41% | -10.63% | 5.01% | 4.15% | Upgrade |
Effective Tax Rate | - | - | - | - | 60.71% | 74.14% | Upgrade |
Revenue as Reported | 2,042 | 2,705 | 2,506 | 3,905 | 9,898 | 5,769 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.